TP53 and rheumatoid arthritis: We also observed significantly lower TP53 mRNA in non-treated and treated patients with RA compared to healthy controls in the discovery cohort (Kruskal-Wallis test p = 0.02) and subsequently demonstrated a similar expression profile in the COMBINE validation cohort (Kruskal-Wallis test p = 0.05) (Fig. 3b).